The updated vaccine is intended to treat children aged five years and above with Covid-19. Credit: Alexxndr/Shutterstock.com. Pfizer and BioNTech have received a marketing authorisation
The companies will develop new therapies for obesity and its related co-morbidities. Credit: abolukbas/Shutterstock.com. Novo Nordisk has acquired Embark Biotech and its lead asset targeting
IMTVO14 immunotherapy comprises a genetically modified HIV virus. Credit: Corona Borealis Studio/Shutterstock.com. Biostax and Immgenuity have entered a research collaboration agreement to expedite the development
TW001 is intended for the treatment of amyotrophic lateral sclerosis. Credit: Green Apple/Shutterstock.com. Specialised Therapeutics (ST) has entered into a licensing agreement with Dutch biotech
Gilead’s Veklury is indicated for the treatment of Covid-19 in people with mild, moderate, and severe hepatic impairment. Credit: Michael We/Shutterstock.com. The US Food and
Plixorafenib demonstrated favourable antitumour activity in patients with BRAF-altered advanced central nervous system tumours. Credit: SciPro/Shutterstock.com. US-based precision oncology company FORE Biotherapeutics has raised $75m
Bristol’s Opdivo is indicated as an adjuvant treatment for stage IIB or IIC melanoma patients. Credit: The agency photographer/Shutterstock.com. The European Commission (EC) has granted
The researcher will study a two-step approach and improve the unhealthy environment in the arthritic knee joint. Credit: PopTika/Shutterstock.com. Hongsik Jake Cho, a researcher at
EYLEA HD is indicated for the treatment of wet age-related macular degeneration. Credit: Image Point Fr/Shutterstock.com. The US Food and Drug Administration (FDA) has granted
DVX201 is being assessed in a Phase I clinical study for treating haematologic malignancies and viral infections. Credit: Kateryna Kon/Shutterstock.com. Coeptis Therapeutics has exclusively licensed